158 Met polymorphism is hypothesized to affect executive function in patient and control populations. Studies inconsistently report better performance on the Wisconsin Card Sort Test (WCST) in individuals with one or more Met alleles. We conducted a meta-analysis of studies published until August 2006 that reported WCST perseverative errors from healthy volunteers or patients with schizophrenia-spectrum disorders. Twelve studies met inclusion criteria (total n = 1910) providing 10 samples each of patients and controls. In healthy controls, individuals with the Met/Met genotype performed better than those with the Val/Val genotype (d = 0.29; 95% confidence interval (CI) 0.02-0.55; P = 0.03), but this was not supported in the patient sample (d = À0.07; 95% CI À0.40 to 0.26; P = 0.68). Post hoc analyses suggested that Val and Met alleles are codominant in their effects on cognition. Effect size was greater in studies published at an earlier date and may also be larger in non-Caucasian samples. Gender did not affect the results. There was no evidence of publication bias. We conclude that there is small but significant relationship between Val 158 Met genotype and executive function in healthy individuals but not in schizophrenia.
Introduction
Catechol-O-methyltransferase (COMT) contributes to enzymatic degradation of dopamine and noradrenaline. The human COMT gene on 22q11 contains a functional polymorphism (Val 158 Met) affecting the activity of the enzyme at body temperature.
1,2 The low-activity Met allele results in slower inactivation of extracellular dopamine within the brain, especially in prefrontal cortex. 2, 3 Presumably because of this increased prefrontal dopamine availability, individuals with the Met allele use their prefrontal cortex more efficiently while carrying out cognitive tasks, showing less prefrontal cortical activation than Val carriers at the same level of task performance. 4 The largest number of studies of COMT and executive function report data from the Wisconsin Card Sort Test (WCST 5 ), an established measure of prefrontal cognitive function. 6 An association between Val 158 Met genotype and WCST perseverative errors has been reported in healthy volunteers and in a number of psychiatric disorders, including people with schizophrenia-spectrum disorders and their healthy relatives. 4, [7] [8] [9] However, other studies have failed to find an association between Met allele frequency and WCST performance. 10, 11 These discrepancies may reflect differences in ethnicity or gender distribution between samples. [12] [13] [14] They might also reflect publication bias such as a tendency to publish positive but not negative findings from small, underpowered association studies.
Met allele frequency has been reported as lower in patients with schizophrenia than in healthy controls. 4 However, recent meta-analyses have questioned the association between schizophrenia and the COMT Val 158 Met polymorphism. [15] [16] [17] Impaired performance on the WCST has long been of interest in schizophrenia because WCST failure is associated with 'hypofrontality', that is a failure to activate the PFC. 6 More recently, WCST performance has attracted considerable interest as a potential endophenotype of schizophrenia, because it shows considerable heritability 18 and is impaired in the healthy relatives of patients with schizophrenia compared with unrelated controls. 19 If the Val allele was both more prevalent in schizophrenia and associated with poorer WCST performance function then this might explain part of the deficit in executive function in schizophrenia.
To determine whether the association between Val
158
Met genotype and executive function is robust, we conducted a meta-analysis of studies reporting COMT genotyping and WCST performance. We examined the relationship first in healthy controls and subsequently in patients with schizophreniaspectrum disorders, as the two groups might be expected to differ greatly in terms of their dopaminergic function and thus the relative impact of COMT genotype on WCST performance.
Materials and methods

Search strategy and study inclusion
The PubMed and PsychInfo databases were searched until the end of August 2006 using combinations of the terms 'catechol-O-methyltransferase', 'COMT', 'Wisconsin Card Sort', 'WCST', 'cognitive' 'cognition' and 'executive function'. The search yielded 17 studies reporting performance on the WCST according to Val 158 Met genotype. Thirteen reported data from healthy volunteers and/or patients with schizophrenia-spectrum disorders. The remainder reported results from patients with ADHD, 20 traumatic brain injury 21 or 22q11 deletion syndrome. 22, 23 These groups were excluded because they might be heterogeneous in terms of the effects of COMT genotype on cognitive function.
Data extraction
Data were independently extracted by two authors (JB and UM). Where data were reported in a format that did not allow inclusion in the meta-analysis, authors were contacted directly and asked to release data in an appropriate format. This allowed inclusion in all but one case. 24 For each study, the following were extracted: authors, month and year of publication, country of origin, reported ethnicity of the sample, diagnostic criteria (if applicable), mean and standard deviation of WCST perseverative error scores for each genotype group (Val/Val, Val/Met, Met/Met). Where more than one study population was reported (e.g. patients and controls), data were treated independently in the analysis.
Statistical analysis
Data were analysed using Comprehensive MetaAnalysis Version 2.0 (Biostat Inc, Englewood, NJ, USA). The entire sample was assessed for heterogeneity using omnibus (Q) tests. Where there was evidence of significant heterogeneity, random-effects analyses were used. Random-effects analyses assume that the samples in the meta-analysis are drawn from a distribution of populations with a corresponding distribution of effect sizes, as opposed to fixed-effects analyses, which assume that that all studies are drawn from a single population. 25 They provide an estimate of the range of effect sizes likely to be observed across populations. Between-group heterogeneity was assessed for patient versus control groups. On the basis of those results, and because it was hypothesized that effects in schizophrenia population might differ from those seen in the healthy population, meta-analyses were completed separately for the two populations. Ethnicity, sex and publication date were assessed as potential moderators of the effect in the combined (patients and controls) samples under a randomeffects model. Ethnicity was assessed through the between-group heterogeneity of the samples, coded as Caucasian (samples reported to comprise entirely individuals of European origin) or non-Caucasian/ mixed ethnicities (including mixed ethnicity samples from the USA, and samples from Asia; see Table 1 ). Effects of the proportion of females in the sample and publication year were assessed using meta-regressions. Compatibility with Hardy-Weinberg equilibrium was assessed for each sample; to check if two samples that were incompatible with Hardy-Weinberg equilibrium were influencing the analysis, post hoc meta-analyses were run excluding these two samples 26, 27 (see Table 1 ). The same procedure was used to assess the impact of two samples that used standardized rather than raw error scores. The effect in related versus unrelated control samples was assessed through the between-group heterogeneity of the samples. Publication bias was assessed using Egger's test. 28 
Results
Included studies are summarized in Table 1 . They comprised 10 samples of schizophrenia-spectrum patients, three samples of healthy relatives of patients, and eight samples of healthy unrelated controls. Given the small number of samples (and consequent low power of the heterogeneity test 29 ), random-effects model were used, and effect sizes were subsequently estimated separately in patients and controls. Under this model, no significant effect of genotype on WCST perseverative errors was found in patients (d = À0.07; 95% confidence interval (CI) À0.40, 0.26; P = 0.68) but a significant effect was found in controls (d = 0.29; 95% CI 0.02, 0.55; P = 0.03; see Figure 1 ). 
Alternative genetic models
Effects of moderators
Effects of ethnicity, sex and publication date on effect size were evaluated across the combined sample (including both patient and control data) using random-effects models under the Met/Met versus Val/Val comparison.
All but four samples were of purely European/ Caucasian ancestry; the remainder were Asian 10 or samples including a mix of ethnicities. 8, 30, 31 The effect of genotype on WCST errors appeared larger in the non-Caucasian samples (d = 0.34; 95%CI 0.05, 0.63; P = 0.02) than in the Caucasian samples (d = 0.05, 95% CI -0.21, 0.31; P = 0.70); however, the between-groups comparison was underpowered owing to the small number of non-Caucasian samples, and failed to reach significance (Q = 2.14, d.f. = 1, P = 0.14).
The proportion of females in the sample did not influence effect size (t 2 = 0.12, Q = 0.70, d.f. = 1, P = 0.40). There was evidence for decreasing effect sizes with later publication dates (t 2 = 0.07, Q = 9.47, d.f. = 1, P = 0.002; see Figure 2 ).
Sensitivity analysis
Two samples were not compatible with HardyWeinberg equilibrium 26, 27 (see Table 1 ). The exclusion of these samples did not alter the main results in patients or controls. Two studies 27, 32 (each comprising one patient and one control sample) reported standardized instead of raw WCST perseverative error scores. Exclusion of these two studies also did not materially alter the effects of the meta-analysis.
There was no difference in the effect of COMT genotype on WCST performance between the healthy siblings of patients with schizophrenia and unrelated controls (Q = 0.29, d.f. = 1, P = 0.59).
Given the trend in publication date, the analysis was repeated with the initial report 4 excluded. The exclusion of this data greatly reduced the effect size and the sample size, and the effect size in controls became nonsignificant (d = 0.22; 95% CI -0.08, 0.52, P = 0.15).
Assessment of publication bias
A funnel plot of all studies (patients and controls) was used to assess publication bias (Figure 3 ). Neither inspection of the funnel plot nor formal assessment Met genotype on WCST perseverative errors in healthy volunteers, with a mean difference of 0.3 standard deviations between the two homozygous groups. No evidence was found for an effect of COMT on this measure of executive cognition in patients with schizophrenia-spectrum disorders.
The trend for decreasing effect sizes with later publication dates (Figure 2 ) may be driven predominantly by the large effect reported in the initial publication. This is a common pattern in genetic association studies. 33 Indeed, excluding the initial report, the published literature as it currently stands does not support the hypothesis of a positive association between COMT genotype and WCST performance. However, it is notable that there was no evidence for publication bias in the combined or control samples (Figure 3) . These results emphasize the need for large samples in molecular genetic studies of cognition: at a = 0.05 (two-tailed), a study would require samples of 188 per group to achieve 80% power to detect a standardized mean difference of 0.29 (the effect size found in controls) and 325 per group to detect a standardized mean difference of 0.22 (that found in control samples excluding the original report). Leaving aside the question of possible moderation by ethnicity, those estimates are substantially larger than the samples included in this analysis.
This meta-analysis studied only WCST perseverative errors, the cognitive measure for which most published data are available. It is clear that similar analyses would be useful for other cognitive functions that have been associated with COMT genotype including working memory. 4, 31, 34 Recent reports have suggested that Val 158 Met genotype may differentially affect cognitive stability and flexibility such that the Met allele is associated with increased cognitive stability but decreased flexibility of cognition. 35 This hypothesis might at first glance suggest an association between Met alleles and increased persevering on the WCST. However, the WCST is a complex task involving multiple cognitive functions including hypothesis generation, self-monitoring and error correction, which may limit its ability to discriminate between cognitive stability and cognitive flexibility. 36 Bilder 36 hypothesizes that the cognitive effects of COMT genotype may be underpinned by differential effects on tonic versus phasic dopaminergic transmission 37 such that the presence of Met alleles increases tonic DA transmission and decreases phasic DA transmission subcortically, resulting in increased D1 and decreased D2 transmission in prefrontal cortex. To test this hypothesis, future studies might use tasks that enable more precise segregation of cognitive processes. However, positive associations with COMT genotype have now been reported across a very broad range of cognitive phenotypes 13, 30, 31, [38] [39] [40] as well as with structural 41, 42 and functional 34, [43] [44] [45] brain measures. These wide-ranging reports suggest that COMT's effects on cognition may be relatively widespread. Alternatively, there may be a publication bias towards the reporting of positive but not negative associations between COMT genotype and diverse cognitive phenotypes; however, we find no evidence that this is the case with the WCST.
Comparison under three genetic models supported the hypothesis that the Met and Val alleles are codominant, as reported in the functional literature. 1, 46 This linear relationship between the number of Met alleles and prefrontal function in healthy controls is not incompatible with an 'inverted-U' relationship between synaptic dopamine levels and prefrontal functioning, 47 assuming that under normal conditions (excluding, for example, psychostimulant administration, 48 ) Met/Met individuals have dopamine levels that are not greater than is cognitively optimal.
One possible explanation for the lack of cognitive effects of genotype in schizophrenia patients may be the effects of antipsychotic medication. The effect of COMT genotype on prefrontal dopamine availability is probably minimal compared with the massive dopamine-blocking effects of antipsychotic drugs. Future studies that included patients on and off medication, or that reported WCST performance in drug-naïve versus drug-treated patients would help to clarify this.
The prevalence of the Met allele varies significantly between populations;
12 the effect sizes reported here Met genotype, schizophrenia and cognition, research has advanced to include analyses of COMT haplotypes rather than individual single nucleotide polymorphisms (SNPs) and cognitive and psychiatric phenotypes, 45, 49 and of the effects of interactions between COMT and other genes involved in monoamine function. [50] [51] [52] [53] [54] There have so far been few reports of the individual effects of other COMT polymorphisms on cognition. 55 Thus although it may be overly simplistic to examine the effects on cognition of any one SNP in isolation, given the known functionality 1 of Val 158 Met and the large amount of research it has motivated, 56 it is nonetheless useful to quantify its individual effects on cognition and other phenotypes.
Despite the substantial recent interest in cognitive impairments as endophenotypes of diverse psychiatric disorders (including schizophrenia 57, 58 bipolar disorder, 59 attention-deficit/hyperactivity disorder 60, 61 and obsessive-compulsive disorder 62 ) replicated associations between candidate genes and specific cognitive functions remain elusive. The marginal nature of the association between COMT genotype and WCST performance revealed here may lessen the popularity of the WCST as a candidate endophenotype for schizophrenia. 63, 64 Nonetheless, these results further demonstrate the value of metaanalysis in assessing the effects of candidate genes on cognitive, and psychiatric, phenotypes, 25 where small samples and false-positive results are common.
